Search Within

Matthew J Matasar

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (42)
  2. Journal Article (33)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (76)
  2. Center for Hematologic Malignancies (76)
  3. Department of Medicine (76)
  4. Epidemiology and Biostatistics (76)
  5. Hematologic Malignancies, Division of (76)
  6. Lymphoma (76)

More Groups

People
  1. Andrew Zelenetz (47)
  2. Craig Moskowitz (46)
  3. Anas Younes (41)
  4. Paul Hamlin (41)
  5. Alison Moskowitz (40)
  6. Steven Horwitz (38)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (8)
  4. 2020 (7)
  5. 2019 (9)
  6. 2018 (10)

More Years

Publications
  1. Blood (26)
  2. Hematological Oncology (10)
  3. Biology of Blood and Marrow Transplantation (8)
  4. Blood Advances (5)
  5. Blood Cancer Journal (5)
  6. Journal of Clinical Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (31)
  2. Elsevier Inc. (13)
  3. Wiley Blackwell (12)
  4. American Society of Clinical Oncology (5)
  5. Nature Publishing Group (5)
  6. John Wiley & Sons (3)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Impact of renal insufficiency and obesity on safety and outcomes of BEAM conditioning
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Zhang, Z.; Shi, W.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save
  • High dose therapy and autologous stem cell transplantation results in good outcomes and acceptable toxicities in elderly patients with non-Hodgkin's lymphoma
    Meeting Abstract

    Tamari, R.; Dahi, P.; Devlin, S.; Goldberg, J.; Hamlin, P.; Matasar, M.; Maragulia, J.; Perales, M. A.; Moskowitz, C. H.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save